跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,697 条关于
“ER+/HER2-”
全部
6,697
临床试验
4,760
药物
495
机构
10
资讯
1,432
去年
Camizestrant Shows Superior Progression-Free Survival Compared to Fulvestrant in ER+, HER2- Breast Cancer
去年
CDK4/6 Inhibitors Maintain Key Role in ER+/HER2- Breast Cancer Treatment Strategies
去年
Niraparib and Dostarlimab Show Promise in BRCA-Mutated, ER+/HER2- Breast Cancer
2年前
Elacestrant Plus Abemaciclib Shows Promise in Pretreated ER+/HER2- Metastatic Breast Cancer
去年
Veru Initiates Phase 2 Trial of Enobosarm Plus Abemaciclib in AR+ ER+ HER2- Metastatic Breast Cancer
11年前
Abemaciclib Shows Promise in ER+/HER2- Advanced Breast Cancer Treatment
去年
Olema Oncology and Pfizer Launch Phase 1b/2 Trial Combining Palazestrant with Atirmociclib for ER+/HER2- Metastatic Breast Cancer
去年
Imlunestrant Shows Promise in Advanced ER+/HER2- Breast Cancer Treatment
2年前
FDA Grants Fast Track Designation to Vepdegestrant for ER+/HER2- Metastatic Breast Cancer
去年
Olema Oncology Secures $250M Funding and Novartis Partnership for Phase 3 Breast Cancer Trial
第 1 页,共 144 页
上一页
下一页